Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News |  Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV ResearchThe Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.
By: KBV Research The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025). The North America market dominated the Global Infectious Diseases Market by Region in 2018, growing at a CAGR of 9.1 % during the forecast period. The Europe market is expected to witness a CAGR of 9.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.2% during (2019-2025). The Sequencing market in the Global Pharmacogenomics Market by Technology would grow at a CAGR of 8 % during the forecast period. The Polymerase Chain Reaction market is expected to witness a CAGR of 8.1% during (2019-2025). Full Report: https://www.kbvresearch.com/ The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company. Global Pharmacogenomics Market Segmentation By Technology Sequencing Polymerase Chain Reaction Electrophoresis Mass Spectrometry Microarray Others By Application Oncology Psychiatry Infectious Diseases Neurological Diseases Pain management Cardiovascular Diseases Others By End User Hospitals and Clinics Research Institutions Academic Institutes By Geography North America US Canada Mexico Rest of North America Europe Germany UK France Russia Spain Italy Rest of Europe Asia Pacific China Japan India South Korea Singapore Malaysia Rest of Asia Pacific LAMEA Brazil Argentina UAE Saudi Arabia South Africa Nigeria Rest of LAMEA Companies Profiled Abbott Laboratories Empire Genomics LLC Illumina, Inc. Oneome LLC Myriad Genetics Inc. Thermo Fisher Scientific, Inc. Teva Pharmaceuticals Industries Ltd. Bayer AG Opko Health, Inc. Becton, Dickinson and Company Unique Offerings from KBV Research Exhaustive coverage Highest number of market tables and figures Subscription based model available Guaranteed best price Assured post sales research support with 10% customization free Pharmacogenomics Market Related Reports: North America Market (https://www.kbvresearch.com/ Europe Market (https://www.kbvresearch.com/ Asia Pacific Market (https://www.kbvresearch.com/ LAMEA Market (https://www.kbvresearch.com/ End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number